Monoclonal Antibody (mABs) Therapeutics Market is Expected to Reach $497.5 billion | MarketsandMarkets™ Chicago, April 09, 2024 (GLOBE NEWSWIRE) -- Monoclonal Antibody (mABs) Therapeutics market in terms of revenue was estimated to be worth $252.6 billion in 2024 and is poised to reach $497.5 billion...

Monoclonal Antibody Therapeutics Market to Surpass US$ 534.26 Billion by 2030, Says Coherent Market Insights (CMI) Burlingame, April 12, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Monoclonal Antibody Therapeutics Market is estimated to be valued at US$ 205.39 Billion in 2023 and is...